About this Journal Submit a Manuscript Table of Contents
International Journal of Rheumatology
Volume 2012 (2012), Article ID 940831, 8 pages
http://dx.doi.org/10.1155/2012/940831
Review Article

Autoantibodies in Autoimmune Pancreatitis

1Institute of Liver Studies, King's College London School of Medicine, King's College Hospital, Denmark Hill, London SE5 9RS, UK
2Department of Medicine, University of Thessaly Medical School, Viopolis, 41110 Larissa, Greece
3The Sheila Sherlock Liver Centre and University Department of Surgery, Royal Free Hospital, London NW3 2QG, UK
4Research Group of Cell Immunotherapy and Molecular Immunodiagnostics, Institute of Biomedical Research & Technology, Centre for Research and Technology-Thessaly (CE.RE.TE.TH), 41222 Larissa, Greece

Received 31 December 2011; Revised 19 April 2012; Accepted 21 April 2012

Academic Editor: Kazuichi Okazaki

Copyright © 2012 Daniel S. Smyk et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Kawa, K. Okazaki, T. Kamisawa, T. Shimosegawa, and M. Tanaka, “Japanese consensus guidelines for management of autoimmune pancreatitis: II. Extrapancreatic lesions, differential diagnosis,” Journal of Gastroenterology, vol. 45, no. 4, pp. 355–369, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Kawano, T. Saeki, H. Nakashima, et al., “Proposal for diagnostic criteria for IgG4-related kidney disease,” Clinical and Experimental Nephrology, vol. 15, no. 5, pp. 615–626, 2011.
  3. A. Khosroshahi and J. H. Stone, “A clinical overview of IgG4-related systemic disease,” Current Opinion in Rheumatology, vol. 23, no. 1, pp. 57–66, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. H. Matsubayashi, H. Sawai, H. Kimura et al., “Characteristics of autoimmune pancreatitis based on serum IgG4 level,” Digestive and Liver Disease, vol. 43, no. 9, pp. 731–735, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Okazaki, “Autoimmune pancreatitis: etiology, pathogenesis, clinical findings and treatment. The Japanese experience,” Journal of the Pancreas, vol. 6, no. 1, pp. 89–96, 2005. View at Scopus
  6. K. Okazaki, K. Uchida, and T. Fukui, “Recent advances in autoimmune pancreatitis: concept, diagnosis, and pathogenesis,” Journal of Gastroenterology, vol. 43, no. 6, pp. 409–418, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Okazaki, K. Uchida, M. Koyabu, H. Miyoshi, and M. Takaoka, “Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease,” Journal of Gastroenterology, vol. 46, no. 3, pp. 277–288, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Zen, D. P. Bogdanos, and S. Kawa, “Type 1 autoimmune pancreatitis,” Orphanet Journal of Rare Diseases, vol. 6, article 82, 2011.
  9. H. Sarles, J. C. Sarles, R. Muratore, and C. Guien, “Chronic inflammatory sclerosis of the pancreas-an autonomous pancreatic disease?” The American Journal of Digestive Diseases, vol. 6, no. 7, pp. 688–698, 1961. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Yoshida, F. Toki, T. Takeuchi, S. Watanabe, K. Shiratori, and N. Hayashi, “Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis,” Digestive Diseases and Sciences, vol. 40, no. 7, pp. 1561–1568, 1995. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Nishimori, A. Tamakoshi, S. Kawa et al., “Influence of steroid therapy on the course of diabetes mellitus in patients with autoimmune pancreatitis: findings from a nationwide survey in Japan,” Pancreas, vol. 32, no. 3, pp. 244–248, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. I. Nishimori, A. Tamakoshi, and M. Otsuki, “Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002,” Journal of Gastroenterology, vol. 42, supplement 18, pp. 6–8, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. D. H. Park, M. H. Kim, and S. T. Chari, “Recent advances in autoimmune pancreatitis,” Gut, vol. 58, no. 12, pp. 1680–1689, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. J. K. Ryu, J. B. Chung, S. W. Park et al., “Review of 67 patients with autoimmune pancreatitis in Korea: a multicenter nationwide study,” Pancreas, vol. 37, no. 4, pp. 377–385, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Hyodo and T. Hyodo, “Ultrasonographic evaluation in patients with autoimmune-related pancreatitis,” Journal of Gastroenterology, vol. 38, no. 12, pp. 1155–1161, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Nishino, F. Toki, H. Oyama et al., “Biliary tract involvement in autoimmune pancreatitis,” Pancreas, vol. 30, no. 1, pp. 76–82, 2005. View at Scopus
  17. A. Ghazale, S. T. Chari, T. C. Smyrk et al., “Value of serum IgG4 in the diagnosis of autoimmune pancreatitis and in distinguishing it from pancreatic cancer,” American Journal of Gastroenterology, vol. 102, no. 8, pp. 1646–1653, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Hamano, S. Kawa, A. Horiuchi et al., “High serum IgG4 concentrations in patients with sclerosing pancreatitis,” The New England Journal of Medicine, vol. 344, no. 10, pp. 732–738, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. H. Hamano, S. Kawa, Y. Ochi et al., “Hydronephrosis associated with retroperitoneal fibrosis and sclerosing pancreatitis,” The Lancet, vol. 359, no. 9315, pp. 1403–1404, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. K. Hirano, Y. Komatsu, N. Yamamoto et al., “Pancreatic mass lesions associated with raised concentration of IgG4,” American Journal of Gastroenterology, vol. 99, no. 10, pp. 2038–2040, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. R. Pezzilli and R. Corinaldesi, “IgG4 as a serological marker of autoimmune pancreatitis: the latest news,” Journal of the Pancreas, vol. 5, no. 6, pp. 531–533, 2004. View at Scopus
  22. S. C. Abraham, M. Cruz-Correa, P. Argani, E. E. Furth, R. H. Hruban, and J. K. Boitnott, “Lymphoplasmacytic chronic cholecystitis and biliary tract disease in patients with lymphoplasmacytic sclerosing pancreatitis,” American Journal of Surgical Pathology, vol. 27, no. 4, pp. 441–451, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. S. M. Weber, O. Cubukcu-Dimopulo, J. A. Palesty et al., “Lymphoplasmacytic sclerosing pancreatitis: inflammatory mimic of pancreatic carcinoma,” Journal of Gastrointestinal Surgery, vol. 7, no. 1, pp. 129–139, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. K. Takuma, T. Kamisawa, and Y. Igarashi, “Autoimmune pancreatitis and IgG4-related sclerosing cholangitis,” Current Opinion in Rheumatology, vol. 23, no. 1, pp. 80–87, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Kamisawa, Y. Tu, N. Egawa, K. Tsuruta, and A. Okamoto, “A new diagnostic endoscopic tool for autoimmune pancreatitis,” Gastrointestinal Endoscopy, vol. 68, no. 2, pp. 358–361, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Kamisawa, Y. Tu, H. Nakajima, N. Egawa, K. Tsuruta, and A. Okamoto, “Usefulness of biopsying the major duodenal papilla to diagnose autoimmune pancreatitis: a prospective study using IgG4-immunostaining,” World Journal of Gastroenterology, vol. 12, no. 13, pp. 2031–2033, 2006. View at Scopus
  27. K. P. Kim, M. H. Kim, J. C. Kim, S. S. Lee, D. W. Seo, and S. K. Lee, “Diagnostic criteria for autoimmune chronic pancreatitis revisited,” World Journal of Gastroenterology, vol. 12, no. 16, pp. 2487–2496, 2006. View at Scopus
  28. M. Otsuki, J. B. Chung, K. Okazaki et al., “Asian diagnostic criteria for autoimmune pancreatitis: consensus of the Japan-Korea symposium on autoimmune pancreatitis,” Journal of Gastroenterology, vol. 43, no. 6, pp. 403–408, 2008. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Shimosegawa, S. T. Chari, L. Frulloni et al., “International consensus diagnostic criteria for autoimmune pancreatitis: guidelines of the international association of pancreatology,” Pancreas, vol. 40, no. 3, pp. 352–358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Zhang, K. Notohara, M. J. Levy, S. T. Chari, and T. C. Smyrk, “IgG4-positive plasma cell infiltration in the diagnosis of autoimmune pancreatitis,” Modern Pathology, vol. 20, no. 1, pp. 23–28, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. T. Ito, I. Nishimori, N. Inoue et al., “Treatment for autoimmune pancreatitis: consensus on the treatment for patients with autoimmune pancreatitis in Japan,” Journal of Gastroenterology, vol. 42, supplement 18, pp. 50–58, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Kamisawa, K. Okazaki, S. Kawa, T. Shimosegawa, and M. Tanaka, “Japanese consensus guidelines for management of autoimmune pancreatitis: III. Treatment and prognosis of AIP,” Journal of Gastroenterology, vol. 45, no. 5, pp. 471–477, 2010. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Kamisawa, T. Shimosegawa, K. Okazaki et al., “Standard steroid treatment for autoimmune pancreatitis,” Gut, vol. 58, no. 11, pp. 1504–1507, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. R. Pannala and S. T. Chari, “Corticosteroid treatment for autoimmune pancreatitis,” Gut, vol. 58, no. 11, pp. 1438–1439, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Masaki, L. Dong, N. Kurose et al., “Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders,” Annals of the Rheumatic Diseases, vol. 68, no. 8, pp. 1310–1315, 2009. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Yamamoto, H. Takahashi, M. Ohara et al., “A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease,” Modern Rheumatology, vol. 16, no. 6, pp. 335–340, 2006. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Taniguchi, M. Ko, S. Seko et al., “Interstitial pneumonia associated with autoimmune pancreatitis,” Gut, vol. 53, no. 5, pp. 770–771, 2004. View at Scopus
  38. Y. Yoshimura, S. Takeda, Y. Ieki, E. Takazakura, H. Koizumi, and K. Takagawa, “IgG-4 associated prostatitis complicating autoimmune pancreatitis,” Internal Medicine, vol. 45, no. 15, pp. 897–901, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Kamisawa, N. Funata, Y. Hayashi et al., “Close relationship between autoimmune pancreatitis and multifocal fibrosclerosis,” Gut, vol. 52, no. 5, pp. 683–687, 2003. View at Publisher · View at Google Scholar · View at Scopus
  40. T. C. Smyrk, “Pathological features of IgG4-related sclerosing disease,” Current Opinion in Rheumatology, vol. 23, no. 1, pp. 74–79, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. M. C. Chang, Y. T. Chang, Y. W. Tien et al., “T-cell regulatory gene CTLA-4 polymorphism/haplotype association with autoimmune pancreatitis,” Clinical Chemistry, vol. 53, no. 9, pp. 1700–1705, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Kawa, M. Ota, K. Yoshizawa et al., “HLA DRB10405-DQB10401 haplotype is associated with autoimmune pancreatitis in the Japanese population,” Gastroenterology, vol. 122, no. 5, pp. 1264–1269, 2002. View at Scopus
  43. T. Umemura, M. Ota, H. Hamano, Y. Katsuyama, K. Kiyosawa, and S. Kawa, “Genetic association of Fc receptor-like 3 polymorphisms with autoimmune pancreatitis in Japanese patients,” Gut, vol. 55, no. 9, pp. 1367–1368, 2006. View at Publisher · View at Google Scholar · View at Scopus
  44. T. Umemura, M. Ota, H. Hamano et al., “Association of autoimmune pancreatitis with cytotoxic T-lymphocyte antigen 4 gene polymorphisms in Japanese patients,” American Journal of Gastroenterology, vol. 103, no. 3, pp. 588–594, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. K. Okazaki, K. Uchida, M. Ohana et al., “Autoimmune-related pancreatitis is associated with autoantibodies and a Th1/Th2-type cellular immune response,” Gastroenterology, vol. 118, no. 3, pp. 573–581, 2000. View at Scopus
  46. K. Uchida, K. Okazaki, Y. Konishi et al., “Clinical analysis of autoimmune-related pancreatitis,” American Journal of Gastroenterology, vol. 95, no. 10, pp. 2788–2794, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. L. Aparisi, A. Farre, L. Gomez-Cambronero et al., “Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis,” Gut, vol. 54, no. 5, pp. 703–709, 2005. View at Publisher · View at Google Scholar · View at Scopus
  48. H. Nishi, A. Tojo, M. L. Onozato et al., “Anti-carbonic anhydrase II antibody in autoimmune pancreatitis and tubulointerstitial nephritis,” Nephrology Dialysis Transplantation, vol. 22, no. 4, pp. 1273–1275, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. I. Nishimori, E. Miyaji, K. Morimoto, K. Nagao, M. Kamada, and S. Onishi, “Serum antibodies to carbonic anhydrase IV in patients with autoimmune pancreatitis,” Gut, vol. 54, no. 2, pp. 274–281, 2005. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Asada, A. Nishio, K. Uchida et al., “Identification of a novel autoantibody against pancreatic secretory trypsin inhibitor in patients with autoimmune pancreatitis,” Pancreas, vol. 33, no. 1, pp. 20–26, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. J. M. Löhr, R. Faissner, D. Koczan et al., “Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process,” American Journal of Gastroenterology, vol. 105, no. 9, pp. 2060–2071, 2010. View at Publisher · View at Google Scholar · View at Scopus
  52. T. Endo, S. Takizawa, S. Tanaka et al., “Amylase α-2A autoantibodies novel marker of autoimmune pancreatitis and fulminant type 1 diabetes,” Diabetes, vol. 58, no. 3, pp. 732–737, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Takizawa, T. Endo, X. Wanjia, S. Tanaka, M. Takahashi, and T. Kobayashi, “HSP 10 is a new autoantigen in both autoimmune pancreatitis and fulminant type 1 diabetes,” Biochemical and Biophysical Research Communications, vol. 386, no. 1, pp. 192–196, 2009. View at Publisher · View at Google Scholar · View at Scopus
  54. L. Frulloni, C. Lunardi, R. Simone et al., “Identification of a novel antibody associated with autoimmune pancreatitis,” The New England Journal of Medicine, vol. 361, no. 22, pp. 2135–2142, 2009. View at Publisher · View at Google Scholar · View at Scopus
  55. T. Yamamoto, Y. Nakamura, J. Nishide, et al., “Molecular cloning and nucleotide sequence of human pancreatic secretory trypsin inhibitor (PSTI) cDNA,” Biochemical and Biophysical Research Communications, vol. 132, no. 2, pp. 605–612, 1985. View at Scopus
  56. Y. Zen, T. Fujii, K. Harada et al., “Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis,” Hepatology, vol. 45, no. 6, pp. 1538–1546, 2007. View at Publisher · View at Google Scholar · View at Scopus
  57. T. Kamisawa, K. Takuma, N. Egawa, K. Tsuruta, and T. Sasaki, “Autoimmune pancreatitis and IgG4-related sclerosing disease,” Nature Reviews Gastroenterology and Hepatology, vol. 7, no. 7, pp. 401–409, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Kawa, H. Hamano, and K. Kiyosawa, Pancreatitis, Mackay Elsevier Academic Press, St Louis, MO, USA, 2006.
  59. D. P. Bogdanos, D. S. Smyk, E. I. Rigopoulou, et al., “Twin studies in autoimmune disease: genetics, gender and environment,” Journal of Autoimmunity, vol. 38, no. 2-3, pp. J156–J169, 2012.
  60. D. Smyk, E. I. Rigopoulou, H. Baum, A. K. Burroughs, D. Vergani, and D. P. Bogdanos, “Autoimmunity and environment: am i at risk?” Clinical Reviews in Allergy and Immunology, vol. 42, no. 2, pp. 199–212, 2012. View at Publisher · View at Google Scholar · View at Scopus
  61. D. S. Smyk, E. I. Rigopoulou, A. Lleo, et al., “Immunopathogenesis of primary biliary cirrhosis: an old wives' tale,” Immunity & Ageing, vol. 8, article 12, 2011.
  62. J. Kino-Ohsaki, I. Nishimori, M. Morita et al., “Serum antibodies to carbonic anhydrase I and II in patients with idiopathic chronic pancreatitis and Sjogren's syndrome,” Gastroenterology, vol. 110, no. 5, pp. 1579–1586, 1996. View at Publisher · View at Google Scholar · View at Scopus
  63. P. D. Hardt, N. Ewald, K. Bröckling et al., “Distinct autoantibodies against exocrine pancreatic antigens in European patients with type 1 diabetes mellitus and non-alcoholic chronic pancreatitis,” Journal of the Pancreas, vol. 9, no. 6, pp. 683–689, 2008. View at Scopus
  64. I. Nishimori, T. Bratanova, I. Toshkov et al., “Induction of experimental autoimmune sialoadenitis by immunization of PL/J mice with carbonic anhydrase II,” Journal of Immunology, vol. 154, no. 9, pp. 4865–4873, 1995. View at Scopus
  65. Y. Ueno, M. Ishii, S. Takahashi, T. Igarashi, T. Toyota, and N. F. LaRusso, “Different susceptibility of mice to immune-mediated cholangitis induced by immunization with carbonic anhydrase II,” Laboratory Investigation, vol. 78, no. 5, pp. 629–637, 1998. View at Scopus
  66. F. Guarneri, C. Guarneri, and S. Benvenga, “Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry?” Journal of Cellular and Molecular Medicine, vol. 9, no. 3, pp. 741–744, 2005. View at Scopus
  67. D. P. Bogdanos and D. Vergani, “Bacteria and primary biliary cirrhosis,” Clinical Reviews in Allergy and Immunology, vol. 36, no. 1, pp. 30–39, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. D. P. Bogdanos, H. Baum, F. Gunsar et al., “Extensive homology between the major immunodominant mitochondrial antigen in primary biliary cirrhosis and Helicobacter pylori does not lead to immunological cross-reactivity,” Scandinavian Journal of Gastroenterology, vol. 39, no. 10, pp. 981–987, 2004. View at Publisher · View at Google Scholar · View at Scopus
  69. A. Koutsoumpas, M. Mytilinaiou, D. Polymeros, G. N. Dalekos, and D. P. Bogdanos, “Anti-helicobacter pylori antibody responses specific for VacA do not trigger primary biliary cirrhosis-specific antimitochondrial antibodies,” European Journal of Gastroenterology and Hepatology, vol. 21, no. 10, p. 1220, 2009. View at Publisher · View at Google Scholar · View at Scopus
  70. J. W. Wiley and M. Pietropaolo, “Autoimmune pancreatitis: the emerging role of serologic biomarkers,” Diabetes, vol. 58, no. 3, pp. 520–522, 2009. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Meagher, Q. Tang, B. T. Fife et al., “Spontaneous development of a pancreatic exocrine disease in CD28-deficient NOD mice,” Journal of Immunology, vol. 180, no. 12, pp. 7793–7803, 2008. View at Scopus
  72. M. Asada, A. Nishio, T. Akamatsu et al., “Analysis of humoral immune response in experimental autoimmune pancreatitis in mice,” Pancreas, vol. 39, no. 2, pp. 224–231, 2010. View at Publisher · View at Google Scholar · View at Scopus